Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

TAKEDA PHARMACEUTICALS AMERICA INC

Filed by FARRAGUT PARTNERS LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-03 06:26:12 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
a97e4170-9719-4548-bdc5-73d06169d620
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues relating to HR 4299 and other heath issues.

Literal federal measure citations: HR 4299

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.